Search

everythinglearnresearchcommunity

for

Search:↓

The top research priorities for congenital ichthyosis include long-term side effects of oral retinoids, best topical treatments, and treatments for itch and hair loss.

Dutch dermatologists prioritized skin conditions like melanoma and psoriasis for guideline development, focusing on consistent care over cost or death rates.

Identified genes linked to male-pattern baldness may help develop new treatments.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

The research identified genes linked to male-pattern baldness and potential drug targets for treatment.

The study created a 27-item measure to assess the impact of skin diseases.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

The study identified the top 10 most important areas for future hair loss research.

MendelVar is a tool that helps identify important genes by combining GWAS data with Mendelian disease information.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

The roadmap calls for better research and funding to improve PCOS diagnosis, treatment, and health outcomes.

A new neural network helps identify key regulators in cell changes, aiding in understanding diseases and finding new treatments.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Patients prefer non-drug methods like massage and music to manage chemotherapy side effects, but standardization is needed.

The method improves hair image segmentation accuracy while reducing annotation costs.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

A mutation in the HR gene causes a rare form of irreversible hair loss in two Kashmiri families. Whole exome sequencing is effective for finding such mutations.

Risk analysis is important for safely adjusting pharmaceutical formulas while maintaining their quality and effectiveness.

Dr. Shoji Okuda's pioneering work on hair transplantation was overlooked and could have significantly advanced the field if recognized sooner.

High-quality validation studies are needed to improve alopecia areata patient-reported outcome measures.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Disease-specific tools better assess quality of life in alopecia areata patients.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.